| Pertuzumab investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 104show all (up to 200) |
|---|
| → investigated in trials for | Malignant Breast Neoplasmcancer_family 126 trials (52 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Breast Neoplasm | 126 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HER2-Positive Breast Carcinomamolecular_subtype 51 trials (27 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | HER2-Positive Breast Carcinoma | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Neoplasmcancer_family 37 trials (20 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Neoplasm | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Carcinoma 8 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Solid Neoplasm 7 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Solid Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Solid Neoplasm 6 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Solid Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Inflammatory Carcinomasubtype 5 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Inflammatory Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Ovarian Neoplasm 5 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Ovarian Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lung Non-Small Cell Carcinomasubtype 4 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lung Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Adenocarcinoma 3 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Invasive Breast Carcinoma 3 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Invasive Breast Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Colon Neoplasm 3 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Colon Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Gastric Neoplasm 3 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Gastric Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Pancreatic Neoplasmcancer 3 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Pancreatic Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Prostate Neoplasm 3 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Prostate Neoplasm | 3 | Observed | clinicaltrials | graph → |